Skip to main content

Technology

EHL's GMP centre: every cell lot quality-tested before release

The GMP quality system EHL uses to produce around 6,000 cell lots a year.

Published 12 Oct 2026 · Updated 12 Oct 2026

EHL BIO operates its cell-manufacturing centre to GMP principles: controlled facilities, trained personnel, written procedures and release testing such as cell count, viability and contamination checks. The centre can produce around 6,000 lots a year, each with traceable documentation. This is the foundation behind the trust of more than 100 partner hospitals in Korea and over 50 overseas.

Source: EHL BIO — GMP center

More in Technology & quality

Experts behind this content

EHL Thailand Medical Information Team — Evidence levels, regulatory status, and separating hospital information from medical information

EHL BIO scientific information is compiled alongside public information from its research team and GMP centre. See the full expert panel

Not sure whether this applies to your case?

Send your questions and initial information through the form. Our team will help prepare your case for an individual assessment with EHL Cell Clinic in Korea.

Consult EHL Thailand